Globus Medical Announces Board Departure

AUDUBON, Pa., March 23, 2026 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that John A. DeFord, PhD, a Director of Globus Medical Inc., notified the company of his decision to step down from the Board of Directors effective immediately and will not seek re-election at the Annual Meeting of Stockholders on June 3, 2026.

“We are grateful for John’s many contributions, especially during the merger with NuVasive and his service on the Nominating and Governance Committee. While we will miss his insights and expertise, we wish him continued success in his future endeavors,” said David C. Paul, Chairman of the Board.

“It has been a privilege and pleasure to serve on the Board of Globus alongside such a dedicated team while experiencing the Company’s significant growth as a leader in musculoskeletal technology,” said Dr. John DeFord.

About Globus Medical, Inc.
Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at .